ABVC BioPharma Achieved its First Operational Profit, with a 102% Improvement over the Third Quarter of Last Year.Incremental Payments Received based on Executed Global Licensing Agreements that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback